Aspire Private Capital’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-251
| Closed | -$19.6K | – | 202 |
|
|
2024
Q3 | $19.6K | Hold |
251
| – | – | ﹤0.01% | 306 |
|
|
2024
Q2 | $19.6K | Hold |
251
| – | – | 0.01% | 317 |
|
|
2024
Q1 | $17K | Hold |
251
| – | – | ﹤0.01% | 340 |
|
|
2023
Q4 | $16.9K | Hold |
251
| – | – | 0.01% | 340 |
|
|
2023
Q3 | $17K | Sell |
251
-1
| -0.4% | -$68 | 0.01% | 334 |
|
|
2023
Q2 | $18K | Hold |
252
| – | – | 0.01% | 303 |
|
|
2023
Q1 | $17.5K | Sell |
252
-4
| -2% | -$278 | 0.01% | 301 |
|
|
2022
Q4 | $17.4K | Hold |
256
| – | – | 0.01% | 307 |
|
|
2022
Q3 | $14K | Sell |
256
-2
| -0.8% | -$109 | 0.01% | 308 |
|
|
2022
Q2 | $17K | Hold |
258
| – | – | 0.01% | 288 |
|
|
2022
Q1 | $17K | Hold |
258
| – | – | 0.01% | 295 |
|
|
2021
Q4 | $15K | Sell |
258
-4
| -2% | -$233 | ﹤0.01% | 300 |
|
|
2021
Q3 | $16K | Buy |
262
+54
| +26% | +$3.3K | 0.01% | 280 |
|
|
2021
Q2 | $12K | Hold |
208
| – | – | ﹤0.01% | 306 |
|
|
2021
Q1 | $10K | Hold |
208
| – | – | ﹤0.01% | 328 |
|
|
2020
Q4 | $10K | Hold |
208
| – | – | ﹤0.01% | 266 |
|
|
2020
Q3 | $11K | Buy |
+208
| New | +$11K | ﹤0.01% | 269 |
|
|
2020
Q2 | – | Sell |
-8
| Closed | – | – | 297 |
|
|
2020
Q1 | $0 | Sell |
8
-228
| -97% | – | ﹤0.01% | 250 |
|
|
2019
Q4 | $12K | Buy |
236
+9
| +4% | +$458 | 0.01% | 254 |
|
|
2019
Q3 | $10K | Hold |
227
| – | – | ﹤0.01% | 251 |
|
|
2019
Q2 | $9K | Buy |
227
+19
| +9% | +$753 | ﹤0.01% | 274 |
|
|
2019
Q1 | $8K | Sell |
208
-7,379
| -97% | -$284K | ﹤0.01% | 328 |
|
|
2018
Q4 | $288K | Buy |
+7,587
| New | +$288K | 0.17% | 100 |
|